Literature DB >> 16583135

On cell signalling mechanism of Mycobacterium leprae soluble antigen (MLSA) in Jurkat T cells.

Beenu Joshi1, Sihem Khedouci, Pradeep Kumar Dagur, Aziz Hichami, Utpal Sengupta, Naim Akhtar Khan.   

Abstract

We investigated the role of Mycobaterium leprae soluble antigen (MLSA) in the modulation of calcium signalling, phosphorylation of mitogen-activated protein (MAP) kinases and IL-2 mRNA expression in human Jurkat T cells. We observed that MLSA induced an increase in free intracellular calcium concentrations, [Ca2+]i, via opening CRAC (Ca2+-release activated- Ca2+) channels. Furthermore, MLSA failed to potentiate both thapsigargin- and anti-CD3 antibodies-induced capacitative calcium influx in Jurkat T cells. We observed that MLSA failed to affect the degree of phosphorylation of two MAP kinases, i.e., ERK1/ERK2, stimulated by anti-CD3 antibodies alone or phorbol 12-myristate 13-acetate (PMA) alone. In order to mimic co-stimulation of T cells, we stimulated them by both PMA and anti-CD3 antibodies. MLSA significantly curtailed the phosphorylation of ERK1/ERK2, stimulated by both PMA and anti-CD3 antibodies in Jurkat T cells. Also MLSA was found to reduce the transcription of IL-2 gene in PMA plus anti-CD3 antibodies-activated Jurkat T cells. Our finding demonstrates that Ca2+ influx via CRAC channels, inhibition of ERK1/ERK2 phosphorylation and IL-2 gene transcription may be implicated in immunosuppressive effects of MLSA antigen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583135     DOI: 10.1007/s11010-006-9132-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

Review 1.  Ion transport, membrane potential, and cytoplasmic pH in lymphocytes: changes during activation.

Authors:  S Grinstein; S J Dixon
Journal:  Physiol Rev       Date:  1989-04       Impact factor: 37.312

2.  The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.

Authors:  I Nath; N Vemuri; A L Reddi; S Jain; P Brooks; M J Colston; R S Misra; V Ramesh
Journal:  Immunol Lett       Date:  2000-12-01       Impact factor: 3.685

3.  We need to know what is happening to the incidence of leprosy.

Authors:  W C Smith
Journal:  Lepr Rev       Date:  1997-09       Impact factor: 0.537

Review 4.  T cell antigen receptor signal transduction pathways.

Authors:  D Cantrell
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.

Authors:  J N Agrewala; B Kumar; H Vohra
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  Alterations in early biochemical events following T cell activation in leprosy patients.

Authors:  N Sharma; V K Sharma; A Gupta; I Kaur; S Kaur; N K Ganguly
Journal:  Clin Immunol Immunopathol       Date:  1998-08

7.  Cellular and humoral immune response to a phenolic glycolipid antigen (PhenGL-I) in patients with leprosy.

Authors:  F T Koster; D M Scollard; E T Umland; D B Fishbein; W C Hanly; P J Brennan; K E Nelson
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

8.  Cellular immunity in lepromatous and tuberculoid leprosy.

Authors:  G Kaplan; Z A Cohn
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

9.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

Authors:  B Frantz; E C Nordby; G Bren; N Steffan; C V Paya; R L Kincaid; M J Tocci; S J O'Keefe; E A O'Neill
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  2 in total

1.  Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.

Authors:  Ambak K Rai; Chandreshwar P Thakur; Amar Singh; Tulika Seth; Sandeep K Srivastava; Pushpendra Singh; Dipendra K Mitra
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

2.  Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases.

Authors:  Pradeep Kumar Dagur; Bhawna Sharma; Rajni Upadhyay; Bhavyata Dua; Arshad Rizvi; Naim Akhtar Khan; Vishwa Mohan Katoch; Utpal Sengupta; Beenu Joshi
Journal:  Lipids Health Dis       Date:  2012-09-17       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.